“The problem needs to be fully recognized, and potential interventions need to be more rigorously pursued” before more definitive treatment recommendations can be made, he said.
In addition to their call for well designed, multicenter clinical trials of migraine interventions in children and adolescents, the guideline authors also highlight the need for standardized criteria for diagnosing migraine headaches and for classifying treatment response in this population.
Further, future research trials should result in increased understanding of observed variations in effects of treatments by age and sex, according to Dr. Lewis.
Both the American Academy of Pediatrics and the American Headache Society have endorsed the new guidelines, according to a press release issued by the American Academy of Neurology.